Health insurance risk assessment has traditionally relied on information collected at specific points in time. Medical histories, diagnostic reports, age, lifestyle declarations, prescription records, and previous claims are commonly used to estimate the probability of future healthcare costs.

Wearable devices are introducing a different type of information into this process. Smartwatches, fitness trackers, continuous glucose monitors, connected blood pressure devices, and other sensors can capture health and activity indicators over extended periods. Instead of providing a single measurement during a medical examination, these devices can reveal patterns in movement, sleep, heart rate, and other physiological signals.

Research using wearable data has demonstrated its potential to provide objective, longitudinal information about physical activity and chronic disease risk. Studies involving wearable-derived activity measurements have found meaningful associations between higher physical activity and lower incidence of several diseases.

For health insurers, this creates an opportunity to assess risk with greater context. However, it also raises important questions about data quality, privacy, fairness, customer consent, and the appropriate role of personal health data in insurance decisions.

Moving Beyond Traditional Health Risk Assessment

Traditional insurance underwriting is largely based on historical and self-reported information. Applicants may complete health questionnaires, disclose existing conditions, undergo medical examinations, or provide access to specific medical records.

These methods remain important, but they have limitations. Self-reported information may be incomplete, outdated, or affected by inaccurate recall. Clinical measurements also represent a person’s condition at a particular moment and may not reflect their normal routine.

Wearables can add a continuous behavioural layer to the assessment process. A device may record whether a person remains physically active over several months, whether their resting heart rate changes gradually, or whether their sleep patterns become increasingly irregular.

This does not mean wearable data can independently determine a person’s health risk. It can instead serve as supplementary evidence that helps insurers develop a more complete and current understanding of risk.

What Health Data Can Wearable Devices Collect?

The capabilities of wearable devices vary depending on their sensors, software, intended purpose, and regulatory classification. Commonly collected measurements include:

Physical Activity and Movement

Fitness trackers can record steps, active minutes, distance travelled, movement intensity, and periods of inactivity. These measurements can help insurers understand long-term activity patterns rather than relying solely on a customer’s description of their lifestyle.

Wearable-based measurements can offer more objective activity information than self-reported surveys, although results may differ between device models, algorithms, and wearing positions.

Heart Rate and Cardiovascular Indicators

Many smartwatches monitor resting heart rate, heart rate during exercise, and changes across time. Some devices can also generate electrocardiogram readings or alert users to possible rhythm irregularities.

These signals may help identify patterns that deserve clinical attention. They should not, however, be treated as confirmed diagnoses unless reviewed through an appropriate medical process.

Sleep Patterns

Wearable devices may estimate sleep duration, wake periods, and sleep consistency. Persistent sleep disruption can be relevant to overall health, but consumer wearables do not always measure sleep with the accuracy of clinical sleep studies.

Insurers therefore need to interpret such information cautiously and avoid drawing conclusions from isolated nights or incomplete records.

Condition-Specific Measurements

Medical-grade connected devices can collect more specialised information. Continuous glucose monitors track glucose levels throughout the day, while connected blood pressure monitors can capture readings over time.

For people managing chronic conditions, this information may offer insight into treatment adherence, stability, and the effectiveness of daily disease management.

How Wearables Improve Insurance Risk Assessment

More Current and Detailed Risk Profiles

Wearable data can help insurers move from static profiles toward continuously updated risk indicators. A medical assessment completed several years ago may no longer reflect a policyholder’s present health behaviour.

Longitudinal data can reveal gradual improvement or deterioration. For example, an individual may become more active after beginning a weight management programme, while another may show a steady decline in activity following a health event.

When interpreted responsibly, these patterns can help insurers refine risk segmentation and develop more relevant support programmes.

Stronger Preventive Health Programmes

Wearables can shift part of the insurer’s focus from predicting claims to helping prevent avoidable health complications.

An insurer might offer voluntary wellness programmes that encourage regular movement, medication adherence, preventive screenings, or improved management of chronic conditions. Participants may receive premium incentives, rewards, coaching support, or access to digital care resources.

The value of these programmes depends on whether they produce meaningful and sustained health improvements. Short-term increases in step counts should not automatically be treated as evidence of lower medical risk.

Earlier Identification of Health Changes

Continuous data may help detect changes before they result in major claims. A noticeable reduction in activity, an unusual increase in resting heart rate, or repeated abnormal readings could indicate that a person needs medical guidance.

Insurers can use such information to support early intervention programmes, provided that alerts are clinically appropriate and customers have consented to the use of their data.

This approach may be particularly valuable in chronic disease management, where early action can reduce complications, hospital admissions, and long-term treatment costs.

More Personalised Insurance Products

Wearable information can support insurance products that respond to individual behaviour rather than relying exclusively on broad demographic categories.

For example, insurers may design optional plans that reward participation in verified health activities or provide additional support to policyholders managing diabetes, cardiovascular conditions, or obesity-related risks.

Personalisation must not become excessive surveillance. Customers should understand what information is collected, why it is collected, how it affects their coverage, and whether participation is genuinely optional.

Key Limitations of Wearable-Based Risk Assessment

Device Accuracy and Data Consistency

Consumer wearable devices are not equally accurate. Measurements may vary based on device quality, sensor placement, skin contact, user movement, firmware updates, and manufacturer algorithms.

The World Health Organization has highlighted several technical issues that affect wearable measurement, including device choice, wear location, algorithm selection, and wear-time criteria.

An insurer should therefore avoid treating every wearable measurement as a verified medical fact. Risk models must account for uncertainty, missing data, device differences, and unusual readings.

Participation Bias

People who use wearable devices consistently may already be more interested in health and fitness. They may also have greater access to technology, reliable internet connectivity, and preventive healthcare services.

Using wearable participation as a risk signal could therefore disadvantage people who cannot afford devices, are uncomfortable with technology, or have disabilities that affect conventional activity measurements.

Fair risk assessment requires insurers to distinguish between health risk and access to digital tools.

Privacy and Informed Consent

Wearable data can reveal sensitive information about a person’s routines, physical condition, location, sleep, and daily behaviour. Insurers must clearly explain how this information will be collected, processed, stored, shared, and deleted.

Insurance regulators continue to examine how consumer information, big data, and artificial intelligence should be governed to protect privacy and prevent unfair outcomes.

Consent should be specific and understandable. Customers should not be pressured into sharing extensive personal data without knowing how it could influence premiums, eligibility, rewards, or claims decisions.

Algorithmic Fairness and Discrimination

Wearable data does not exist outside social and medical context. A low activity level may be related to disability, injury, pregnancy, age, work conditions, caregiving responsibilities, or limited access to safe exercise spaces.

A risk model that rewards movement without considering these factors could produce unfair results. Insurers need regular bias testing, human oversight, explainable decision processes, and mechanisms that allow customers to challenge inaccurate conclusions.

The Future of Wearables in Health Insurance

Wearables are likely to become one component of a broader digital health ecosystem that includes electronic health records, remote patient monitoring, telehealth services, connected medical devices, and predictive analytics.

Their most responsible use may not be to replace traditional underwriting. It may be to improve prevention, identify emerging risks, support chronic disease management, and create more responsive insurance services.

The strongest insurance models will combine wearable information with verified clinical data, customer context, transparent policies, and careful human judgement. Technology can improve the quality of risk assessment, but it should not reduce individuals to a collection of daily scores.

Conclusion

Wearable devices are changing health insurance risk assessment by providing continuous information about activity, sleep, cardiovascular signals, and condition management. This data can help insurers understand risk patterns, support preventive care, identify health changes earlier, and develop more personalised programmes.

The benefits will depend on how responsibly the information is used. Reliable measurements, voluntary participation, strong privacy controls, fair algorithms, and transparent decision-making must remain central to implementation.

As insurers modernise their platforms, medical insurance software development services can support secure wearable integrations, consent management, risk analytics, clinical data exchange, and customer-facing wellness programmes. The goal should not be to monitor every action, but to use relevant health information carefully to improve prevention, fairness, and long-term outcomes.